These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


483 related items for PubMed ID: 36515653

  • 1. Clinical and MRI measures to identify non-acute MOG-antibody disease in adults.
    Cortese R, Battaglini M, Prados F, Bianchi A, Haider L, Jacob A, Palace J, Messina S, Paul F, Wuerfel J, Marignier R, Durand-Dubief F, de Medeiros Rimkus C, Callegaro D, Sato DK, Filippi M, Rocca MA, Cacciaguerra L, Rovira A, Sastre-Garriga J, Arrambide G, Liu Y, Duan Y, Gasperini C, Tortorella C, Ruggieri S, Amato MP, Ulivelli M, Groppa S, Grothe M, Llufriu S, Sepulveda M, Lukas C, Bellenberg B, Schneider R, Sowa P, Celius EG, Proebstel AK, Yaldizli Ö, Müller J, Stankoff B, Bodini B, Carmisciano L, Sormani MP, Barkhof F, De Stefano N, Ciccarelli O, MAGNIMS Study Group.
    Brain; 2023 Jun 01; 146(6):2489-2501. PubMed ID: 36515653
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis.
    Mariano R, Messina S, Roca-Fernandez A, Leite MI, Kong Y, Palace JA.
    Brain; 2021 Feb 12; 144(1):198-212. PubMed ID: 33206944
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis.
    Molazadeh N, Akaishi T, Bose G, Nishiyama S, Chitnis T, Levy M.
    Mult Scler Relat Disord; 2023 Dec 12; 80():105093. PubMed ID: 37949025
    [Abstract] [Full Text] [Related]

  • 8. Comparison of Clinical Outcomes of Transverse Myelitis Among Adults With Myelin Oligodendrocyte Glycoprotein Antibody vs Aquaporin-4 Antibody Disease.
    Mariano R, Messina S, Kumar K, Kuker W, Leite MI, Palace J.
    JAMA Netw Open; 2019 Oct 02; 2(10):e1912732. PubMed ID: 31596489
    [Abstract] [Full Text] [Related]

  • 9. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
    Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J, Küker W, Chandratre S, Vincent A, Palace J.
    JAMA Neurol; 2014 Mar 02; 71(3):276-83. PubMed ID: 24425068
    [Abstract] [Full Text] [Related]

  • 10. Quantitative brain lesion distribution may distinguish MOG-ab and AQP4-ab neuromyelitis optica spectrum disorders.
    Yang L, Li H, Xia W, Quan C, Zhou L, Geng D, Li Y.
    Eur Radiol; 2020 Mar 02; 30(3):1470-1479. PubMed ID: 31748853
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder.
    Cai MT, Zheng Y, Shen CH, Yang F, Fang W, Zhang YX, Ding MP.
    Mult Scler; 2021 May 02; 27(6):871-882. PubMed ID: 32672091
    [Abstract] [Full Text] [Related]

  • 12. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M, Daoudi S, Hattab S, Bouzar AA, Deiva K, Wildemann B, Reindl M, Jarius S.
    J Neurol Sci; 2017 Oct 15; 381():240-244. PubMed ID: 28991690
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease?
    Papais Alvarenga RM, Araújo ACRAE, Nascimento ACB, Araujo NEC, Meneguette NS, Neri VC, Papais Alvarenga M, Filho HA, Barros PO, Bento CA, Schmidt SL, Vasconcelos CCF, Alvarenga MP.
    Mult Scler Relat Disord; 2020 Jul 15; 42():102082. PubMed ID: 32361664
    [Abstract] [Full Text] [Related]

  • 15. Correlations among disability, anti-AQP4 antibody status and prognosis in the spinal cord involved patients with NMOSD.
    Hsu JL, Liao MF, Chang KH, Cheng MY, Ro LS.
    BMC Neurol; 2021 Apr 09; 21(1):153. PubMed ID: 33836682
    [Abstract] [Full Text] [Related]

  • 16. Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder.
    Camera V, Holm-Mercer L, Ali AAH, Messina S, Horvat T, Kuker W, Leite MI, Palace J.
    JAMA Netw Open; 2021 Dec 01; 4(12):e2137833. PubMed ID: 34878547
    [Abstract] [Full Text] [Related]

  • 17. Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity.
    Chien C, Scheel M, Schmitz-Hübsch T, Borisow N, Ruprecht K, Bellmann-Strobl J, Paul F, Brandt AU.
    Mult Scler; 2019 Dec 01; 25(14):1926-1936. PubMed ID: 30475082
    [Abstract] [Full Text] [Related]

  • 18. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype.
    Pröbstel AK, Rudolf G, Dornmair K, Collongues N, Chanson JB, Sanderson NS, Lindberg RL, Kappos L, de Seze J, Derfuss T.
    J Neuroinflammation; 2015 Mar 08; 12():46. PubMed ID: 25889963
    [Abstract] [Full Text] [Related]

  • 19. Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis.
    Cortese R, Battaglini M, Prados F, Gentile G, Luchetti L, Bianchi A, Haider L, Jacob A, Palace J, Messina S, Paul F, Marignier R, Durand-Dubief F, de Medeiros Rimkus C, Apostolos Pereira SL, Sato DK, Filippi M, Rocca MA, Cacciaguerra L, Rovira À, Sastre-Garriga J, Arrambide G, Liu Y, Duan Y, Gasperini C, Tortorella C, Ruggieri S, Amato MP, Ulivelli M, Groppa S, Grothe M, Llufriu S, Sepulveda M, Lukas C, Bellenberg B, Schneider R, Sowa P, Celius EG, Pröbstel AK, Granziera C, Yaldizli Ö, Müller J, Stankoff B, Bodini B, Barkhof F, Ciccarelli O, De Stefano N, MAGNIMS Study Group.
    Ann Neurol; 2024 Aug 08; 96(2):276-288. PubMed ID: 38780377
    [Abstract] [Full Text] [Related]

  • 20. Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease.
    Camera V, Mariano R, Messina S, Menke R, Griffanti L, Craner M, Leite MI, Calabrese M, Meletti S, Geraldes R, Palace JA.
    Brain Commun; 2023 Aug 08; 5(3):fcad107. PubMed ID: 37180990
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.